![Peter J. Savino](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter J. Savino
Presidente en The Graduate Hospital .
Cargos activos de Peter J. Savino
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Wills Eye Health System & Wills Eye Institute
![]() Wills Eye Health System & Wills Eye Institute Medical/Nursing ServicesHealth Services Wills Eye Health System & Wills Eye Institute is a renowned ophthalmology hospital established in 1832 as the first hospital in the United States specializing in eye care. The hospital is located in Philadelphia, PA. Wills Eye is consistently ranked as one of America's top ophthalmology hospitals by U.S. News & World Report and has the most nationally ranked ophthalmologists in the country. It is also the #1 academic training for its residency program as voted by physicians in the nation. Wills Eye provides a full range of primary and subspecialty eye care services, including cataract, cornea, retina, emergency care, glaucoma, neuro-ophthalmology, ocular oncology, oculoplastics, pathology, pediatric ophthalmology and ocular genetics, and refractive surgery. The hospital also has a network of seven multi-specialty, ambulatory surgery centers throughout the tristate area. | Corporate Officer/Principal | 01/01/1983 | - |
The Graduate Hospital
![]() The Graduate Hospital Hospital/Nursing ManagementHealth Services The Graduate Hospital operates as a long term rehabilitation facility. The company was founded in 1917 and is headquartered in Philadelphia, PA. | Presidente | 01/01/1980 | - |
Historial de carrera de Peter J. Savino
Antiguos cargos conocidos de Peter J. Savino.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Genaera Corp.
![]() Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | Director/Miembro de la Junta | 22/03/2006 | - |
Formación de Peter J. Savino.
Manhattan College | Undergraduate Degree |
Alma Mater Studiorum - Università di Bologna | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 5 |
Italia | 2 |
Operativa
Director/Board Member | 1 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectorial
Health Services | 3 |
Consumer Services | 3 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Genaera Corp.
![]() Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | Health Technology |
Wills Eye Health System & Wills Eye Institute
![]() Wills Eye Health System & Wills Eye Institute Medical/Nursing ServicesHealth Services Wills Eye Health System & Wills Eye Institute is a renowned ophthalmology hospital established in 1832 as the first hospital in the United States specializing in eye care. The hospital is located in Philadelphia, PA. Wills Eye is consistently ranked as one of America's top ophthalmology hospitals by U.S. News & World Report and has the most nationally ranked ophthalmologists in the country. It is also the #1 academic training for its residency program as voted by physicians in the nation. Wills Eye provides a full range of primary and subspecialty eye care services, including cataract, cornea, retina, emergency care, glaucoma, neuro-ophthalmology, ocular oncology, oculoplastics, pathology, pediatric ophthalmology and ocular genetics, and refractive surgery. The hospital also has a network of seven multi-specialty, ambulatory surgery centers throughout the tristate area. | Health Services |
The Graduate Hospital
![]() The Graduate Hospital Hospital/Nursing ManagementHealth Services The Graduate Hospital operates as a long term rehabilitation facility. The company was founded in 1917 and is headquartered in Philadelphia, PA. | Health Services |
- Bolsa de valores
- Insiders
- Peter J. Savino
- Experiencia